Description

2-(2,3-Dihydrobenzofuran-5-Yl)-n-(6-Methylbenzo[D]Thiazol-2-Yl)Acetamide is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of novel active pharmaceutical ingredients (APIs). This compound matters because it provides a critical, structurally complex building block essential for modern drug discovery and development programs, particularly in oncology and central nervous system (CNS) research. Pharmaceutical R&D laboratories, fine chemical manufacturers, and contract research organizations (CROs) need this high-value intermediate to accelerate their lead optimization and preclinical studies.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel small-molecule drug candidates targeting specific biological pathways.
• Oncology Research: Used in the development of potential therapeutic agents for various cancer types due to its fused heterocyclic scaffold.
• CNS Drug Discovery: Serves as a core structure for designing compounds aimed at neurological and psychiatric disorders.
• Kinase Inhibitor Development: The molecular architecture is suitable for creating selective kinase inhibitors, a major class of targeted therapies.
• Chemical Biology: Employed as a probe or tool compound to study protein-ligand interactions and enzyme function.
• Custom Synthesis: Supplied to fine chemical companies for bespoke synthesis projects under cGMP or research-grade conditions.

Basic Information

Product Name	2-(2,3-Dihydrobenzofuran-5-Yl)-n-(6-Methylbenzo[D]Thiazol-2-Yl)Acetamide
CAS No.	1262138-64-6
Molecular Formula	C20H18N2O2S
Molecular Weight	350.44 g/mol
Synonyms	2-(2,3-Dihydrobenzofuran-5-yl)-N-(6-methyl-1,3-benzothiazol-2-yl)acetamide; 2-(2,3-Dihydro-5-benzofuranyl)-N-(6-methyl-2-benzothiazolyl)acetamide; 1262138-64-6; Acetamide, 2-(2,3-dihydro-5-benzofuranyl)-N-(6-methyl-2-benzothiazolyl)-; N-(6-methylbenzo[d]thiazol-2-yl)-2-(2,3-dihydrobenzofuran-5-yl)acetamide
EINECS	Contact for details

Quality Control

Our 2-(2,3-Dihydrobenzofuran-5-Yl)-n-(6-Methylbenzo[D]Thiazol-2-Yl)Acetamide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with every shipment, detailing all critical quality attributes. Our production can be aligned with research-grade or cGMP standards to meet the specific requirements of preclinical and clinical development phases.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). The container should be kept tightly sealed in a dry environment to minimize moisture uptake. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Residual Solvents (GC)	Complies with ICH Q3C

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.